Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Three arrested in Paris after attempted bomb attack outside Bank of America- Ethiopian earthquakes and volcanic eruptions: earth scientist explains the link
- Civil rights leader Jesse Jackson hospitalized, family requests prayers
- Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- Figure out How to Get a good deal on Your Rooftop Substitution Venture
- Was This Driver Simply Having A great time Or Behaving Like An Ass?
- 4 Creative Savvy Home Gadgets of 2024: Reforming Home Robotization and Security
- Merck sees over $5 billion opportunity in Cidara's experimental flu drug
- Comet C/2025 K1 (ATLAS) breaks apart in incredible telescope photos
